Three medicines available through Cyprus’s General Health System (GHS) are currently in short supply, affecting patients with chronic conditions including thyroid disorders, psychiatric illnesses and certain cancers, with suppliers unable to deliver the required quantities within agreed timeframes. The most serious shortage involves Carbimazole 5mg, used to treat hyperthyroidism and Graves disease. Doctors have been … Continue reading Thyroid drug unavailable through GHS until 2027 as three medicines run short